Measuring acid reflux with a wireless electrode can help clinicians determine if patients can stop taking proton pump inhibitors, a medication commonly prescribed for gastroesophageal reflux disease.
Browsing: Clinical Breakthroughs
A first of its kind drug called vosoritide may increase bone growth in children with achondroplasia, the most common form of dwarfism, according to findings from a recent clinical trial.
A nationwide clinical trial has found that patients taking antibiotics for appendicitis reported the same quality of life measures as those who underwent surgery.
Northwestern investigators have developed a novel vaccine that utilizes a specialized group of B-cells to promote anti-tumor immunity against glioblastoma.
The drug rucaparib significantly delayed cancer progression for women with ovarian cancer and may be an effective option for maintenance therapy, according to findings from a recent clinical trial.
A new immunotherapy treatment for recurrent B-cell lymphoma was found to be safe in a trial of nearly 350 patients, according to a study published in The Lancet.
Starting cholesterol-lowering treatment earlier may increase the its benefits, reducing heart attack and stroke over time, according to a Northwestern Medicine study.
Men with advanced prostate cancer who were treated based on the genetic makeup of their cancer survived significantly longer than those treated with standard treatments, according to a new study.
Biomarkers using mass cytometry can assess patient response to an emerging treatment for pediatric brain tumors, according to a recent multi-center study.
Lifestyle advice has been only somewhat effective in controlling or slowing the progression of nonalcoholic fatty liver disease in children, according to a recent study published in Gastroenterology.